A dose of the Pfizer COVID-19 vaccine in New York, 2020. Johnson & Johnson is the third vaccine candidate to apply for emergency use authorization from the FDA. The vaccine requires a single dose and doesn't require ultra-cold temperatures for storage. (AP)
